Skip to content
thestock.space

On 6 Nov 2026, Krishna Institute of Medical Sciences was priced at ₹723.00, or 138.5× trailing earnings, against an industry P/E of 47.7×, and the shares are 16% below their 52-week high. Its ROCE of 8.1% is the lowest among the 7 largest Medical Care Facilities peers, and sales grew 21% a year over 3 years while net profit fell 10%. Debt is 1.66× equity. It is a small-cap company with a market cap of ₹30,366 Cr, ranked 8th of 40 Medical Care Facilities companies by market cap; the shares rose 2.0% over the past year.

As of 6 Nov 2026Prices are delayed about 15 minutes; fundamentals are from the quarter ended Sep 2026.How we calculate this

past year
Open
₹731.20
Day high
₹737.50
Day low
₹717.35
Prev. close
₹731.05
Volume
6.7 L

Health check

2 fair · 4 to check
  • ReturnsIn line

    +2.0% over a year, better than 3 of 7 peers.

  • Price tagPricier

    P/E 138.5 vs industry 47.7.

  • GrowthSteady

    Sales +21.3%, profit −10.5% a year over 3 years.

  • ProfitabilityWeak

    ROCE 8.1% vs peer median 11.9%.

  • Balance sheetStretched

    Debt 1.66× equity, interest covered 2.7×, Piotroski 4 of 9.

  • Red flags2 to check

    Debt is 1.66× equity.

Compared with 7 industry peers. Computed from reported figures. Educational, not a recommendation.

Medical Care Facilities

39 listed peers. Screen the industry

Small cap

₹30,366 Cr, #8 of 40 in its industry by size.

Defensive

Beta 0.33 vs the NIFTY 50: moves less than the market.

Key metrics

Last 12 months to Sep 2026: sales ₹4,213 Cr · profit ₹204 Cr
Market cap
₹30,366 Cr
Small cap
P/E
138.5
Industry 47.7
Price to book
12.87
Peers 8.06
Dividend yield
0.00%
ROE
11.0%
Peers 12.8%
ROCE
8.1%
Peers 11.9%
Debt to equity
1.66
Debt ₹4,253 Cr
EPS (TTM)
₹5.22
Face value ₹2
OPM (TTM)
19.3%
Net margin 4.8%
Sales growth
+39.9%
Latest quarter vs a year ago
Profit growth
+12.1%
Latest quarter vs a year ago
Price to sales
7.21
EV/EBITDA 44.9

Strengths and risks

Strengths

  • Quarterly sales up 39.9% on a year ago.
  • Positive operating cash flow in each of the last 4 years.

Risks to check

  • Debt is 1.66× equity.
  • P/E of 138.5 against an industry P/E of 47.7.

Derived automatically from reported figures. Not a recommendation.

About Krishna Institute of Medical Sciences

Krishna Institute of Medical Sciences Limited provides medical and health care services under the KIMS Hospitals brand in India. The company offers arthroscopy and shoulder, cardiology, cardiothoracic and cardiovascular, organ transplant, medical and surgical gastroenterology, hepatology, orthopaedic, neurology, neurosurgery, nephrology, urology, oncology, pediatric, neonatology, obstetrics and gynaecology, fertility, dental science, emergency and…

Headquarters
Secunderabad
Sector
Healthcare
ISIN
INE967H01025
Website
kimshospitals.com

Price range

52 weeks

₹575.80₹858.00

Today

₹717.35₹737.50
Avg volume (3M)
5.2 L
1-year return
plus 2.0%
From 52-week high
minus 15.7%

Analyst consensus

16 analysts
Strong buyMean target ₹864.25 plus 19.5%

Target range, with today’s price

Low ₹680.00High ₹1,000.00

Next results expected around 4 Feb 2027

Consensus from Yahoo Finance. Not a recommendation.

Peers · Medical Care Facilities

Compare with peersScreen the whole industry
Company
APOLLOHOSPApollo Hospitals Enterprise8,446.00plus 0.90%1,21,44154.011.4519.2%22.5%15.4%14.8%33.3%0.24%plus 7.2%
MAXHEALTHMax Healthcare Institute934.00plus 0.21%90,90966.18.0312.6%12.8%26.8%22.4%9.3%0.21%minus 18.1%
MANIPALHOSManipal Health Enterprises646.70minus 1.61%85,065133.69.059.8%9.2%17.8%––0.00%minus 3.0%
ASTERDMAster DM Quality Care713.15minus 0.89%62,09290.78.069.4%9.7%17.4%15.7%−3.0%0.42%plus 4.5%
FORTISFortis Healthcare766.90minus 6.45%57,89855.75.5211.9%10.4%22.2%13.3%20.9%0.13%minus 19.6%
NHNarayana Hrudayalaya1,903.00minus 0.65%38,65044.77.7311.4%19.1%18.5%20.5%9.9%0.24%plus 4.7%
MEDANTAGlobal Health1,387.60minus 0.15%37,26460.48.6315.0%15.2%22.1%17.2%19.5%0.04%plus 11.2%
KIMSKrishna Institute of Medical Sciences723.00minus 1.10%30,366138.512.878.1%11.0%19.8%21.3%−10.5%0.00%plus 2.0%
Median of 7 peers–−0.65%62,09260.48.0611.9%12.8%18.5%16.5%14.7%0.21%4.5%

Quarterly results

Consolidated, ₹ crore
SalesSelect a row below to chart it
₹ CrSep 25Dec 25Mar 26Jun 26Sep 26
9619981,0751,1801,344
7577998689561,084
204199207223260
21.2%19.9%19.2%18.9%19.4%
4.25.212.317.418.2
4556.868.183.465.5
66.178.785101121
−0.3–−10.9–13.2
96.868.654.856.6106
25.6%24.3%39.6%33.9%29.3%
66.953.442.541.575
1.671.331.061.041.79

Profit & loss

Yearly, ₹ crore
Sales CAGR 3Y
+21.3%
Profit CAGR 3Y
−10.5%
EPS CAGR 3Y
−10.5%
ROE
11.0%
Net profitSelect a row below to chart it
₹ CrMar 2023Mar 2024Mar 2025Mar 2026
2,1682,4743,0043,872
–+14.1%+21.4%+28.9%
1,5571,8262,2113,054
611648793819
28.2%26.2%26.4%21.1%
14.20.146.4
29.346.488.7197
129147177283
18.44.527−11.2
485460558334
24.6%26.9%25.7%27.5%
336310385241
–minus 7.8%+24.0%minus 37.2%
8.417.759.616.03

Forecast

Your assumptions, not a prediction

Balance sheet

At each financial year end, ₹ crore
Total assetsSelect a row below to chart it
₹ CrMar 2023Mar 2024Mar 2025Mar 2026
80808080
1,5901,7482,0582,167
6781,3562,5624,253
5946681,0371,258
2,9413,8525,7367,759
1,9532,7154,3726,054
5726541,430740
00.70.60.6
1341307870.5
282353−145894
2,9413,8525,7367,759

Cash flow

Yearly, ₹ crore
Cash from operationsSelect a row below to chart it
₹ CrMar 2023Mar 2024Mar 2025Mar 2026
432521582511
−547−753−1,116−1,452
19.6217543940
−95.2−14.78.7−0.6
−575−647−1,009−1,428
−142−126−427−917

Shareholding pattern

Source: NSE filings

NSE hasn’t returned a shareholding pattern for this company. Institutions hold about 41.2% (Yahoo estimate).

Major shareholders

NSE filing

Filings & events

News

No recent news coverage found.

My notes

Private to you